Financial Results Highlights
Japan's Takeda agrees to pay $2.4B ln in diabetes drug suit
Takeda Pharmaceutical Company - Wikipedia
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact | Fierce Biotech
Takeda | Das Informationsportal für die Pharmaproduktion, Management & Technik
Aktuelle News der FAZ zu Unternehmen aus der Wirtschaft
France pulls Takeda diabetes drugs after cancer fears | Pharmafile
Missing safety risk emails draw $9bn Actos fine | Business | Chemistry World
Court awards $6bn to cancer patient over Takeda's diabetes drug | The Times
Takeda loses cancer suit over Actos | The Japan Times
Takeda trial win in Hatch-Waxman case involving diabetes products upheld by Federal Circuit | Experience | Jones Day
2º Fórum Takeda Diabetes e TCA – Apps bei Google Play
Takeda UK
Takeda on Twitter: "#DYK: The rate of Type 2 #diabetes is higher in urban areas than rural areas. https://t.co/JBI3E9JkAL" / Twitter
Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin | Fierce Pharma
Takeda's Nesina doesn't raise the risk of death in diabetic ACS patients, new analysis says | Fierce Pharma
Takeda har succes med diabetes-forsøg
Takeda Pharmaceutical Company - Wikipedia
Validity of Takeda's Diabetes Drug Patent Upheld by Fed. Cir.
Krebsrisiko vertuscht - Milliardenstrafe für Pharmakonzerne • NEWS.AT
Takeda Diabetes Drugs AdaComp
Takeda veräußert vier Diabetes-Produkte in Japan an Teijin Pharma Limited | Business Wire
Takeda's Oral Medication Actos Goes Generic, Making it Significantly Cheaper
Takeda Advances Diabetes Drug Development at the ALS
